Jiangsu, China

Qingli Dong

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Jiangsu Simovay Pharmaceutical Co., Ltd.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qingli Dong. Retrieved from https://idiyas.com/inventor/qingli-dong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qingli Dong: Innovator in Pharmaceutical Development

Introduction

Qingli Dong is a notable inventor based in Nanjing, China. He is currently associated with Yantai Yenepharma Co., Ltd., where he contributes to advancements in the pharmaceutical industry. Despite having no patents to his name, his work is significant in the field.

Latest Patents

As of now, Qingli Dong has not registered any patents. This does not diminish his contributions to the industry, as he is involved in various innovative projects.

Career Highlights

Qingli Dong has built a career focused on pharmaceutical research and development. His role at Yantai Yenepharma Co., Ltd. allows him to engage in cutting-edge research that aims to improve healthcare solutions.

Collaborations

Qingli Dong collaborates with talented coworkers such as Rong Chen and Lin Feng. Together, they work on projects that push the boundaries of pharmaceutical innovation.

Conclusion

Qingli Dong is an influential figure in the pharmaceutical sector, contributing to important research and development efforts. His work, although not yet recognized through patents, plays a vital role in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…